Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why the FTC Is About to Lose Its Fight Over Sleep Disorder Pills
BNET Pharma
Thursday, August 12, 2010 - 7:43am
tags:
FTC, Watson Pharmaceuticals, Cephalon, Provigil, Apotex
Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up
BNET Pharma
Wednesday, August 11, 2010 - 6:10pm
tags:
Shire, ADHD, Daytrana
ADVENTRX Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Wednesday, August 11, 2010 - 5:43pm
tags:
Adventrx
Health giant Johnson & Johnson discloses new subpoenas over consumer recalls, factory problems
Yahoo/AP
Wednesday, August 11, 2010 - 5:42pm
tags:
JNJ, recalls, Tylenol
Dang! This Drug Is Shining Brighter
Motley Fool
Wednesday, August 11, 2010 - 5:40pm
tags:
Vertex Pharmaceuticals, hepatitis C, Merck, Telaprevir, Boceprevir, Roche, PegIntron, Pegasys
FDA panel favors Glaxo epilepsy drug
Yahoo/AP
Wednesday, August 11, 2010 - 5:38pm
tags:
GSK, epilepsy, Potiga, FDA, advisory panels, JNJ, Pfizer, Valeant Pharmaceuticals
[video]Lexicon an Attractive Takeover Candidate
Yahoo/Morningstar
Wednesday, August 11, 2010 - 5:36pm
tags:
diabetes, Lexicon Pharmaceuticals
Did the Market Overreact to Curis's Latest Setback?
Seeking Alpha
Wednesday, August 11, 2010 - 11:32am
tags:
hedgehog pathway inhibitor, Curis
Amgen: Vectibix fails in head and neck cancer test
Yahoo/AP
Wednesday, August 11, 2010 - 11:31am
tags:
head and neck cancer, Amgen, Vectibix
Genzyme in the red amid more discarded drugs
Mass High Tech
Wednesday, August 11, 2010 - 11:14am
tags:
Genzyme, earnings
Gilead facility may get FDA warning letter
Bizjournals.com
Wednesday, August 11, 2010 - 11:12am
tags:
FDA, warnings, Gilead Sciences
Biovail, Valeant set shareholder merger vote date
Yahoo/AP
Wednesday, August 11, 2010 - 11:11am
tags:
M&A, Biovail, Valeant Pharmaceuticals
DepoMed starts new late-stage Serada trial
Yahoo/AP
Wednesday, August 11, 2010 - 11:11am
tags:
Serada, Depomed, clinical trials, hot flashes
Cardiome shares tumble on heart drug delay
Yahoo/AP
Wednesday, August 11, 2010 - 11:10am
tags:
Cardiome, Merck, atrial fibrillation
When the Disease Matters Most in Drug Approval
Motley Fool
Wednesday, August 11, 2010 - 11:08am
tags:
drug development, JNJ, Vivus, Valeant Pharmaceuticals, GSK, Pfizer, Abbott Laboratories
Technically, MannKind Is a Buy
Motley Fool
Wednesday, August 11, 2010 - 11:03am
tags:
diabetes, inhaled insulin, MannKind, Afrezza
Momenta Poised to Dominate $100B Blood Thinners Industry
Seeking Alpha
Wednesday, August 11, 2010 - 9:53am
tags:
Momenta, blood thinners, biogenerics, Lovenox, Sanofi
Lilly to Indiana: We're shrinking for keeps
Indianapolis Star, IN
Wednesday, August 11, 2010 - 9:19am
tags:
Eli Lilly, layoffs, Indiana
Merck Prostate Cancer Medicine Merits More Attention
Bloomberg
Wednesday, August 11, 2010 - 9:14am
tags:
prostate cancer, Proscar, Merck
Marginal Performance at Abbott Laboratories
Motley Fool
Wednesday, August 11, 2010 - 9:12am
tags:
Abbott Laboratories, Valeant Pharmaceuticals, Merck, Celgene, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.